JR

Jala Ranjith

Active Director Director DIN 10643899
DIN 10643899 First appointment May 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Jala Ranjith

Data last updated:

Jala Ranjith is a Director at Innopeptichem Life Sciences Private Limited (since 2024). The company operates in Paper. Innopeptichem Life Sciences Private Limited reported revenue of ₹3.3 Lakh (FY 2025).

DIN 10643899
Primary Designation Director
Industry Paper
First Appointment 31 May 2024
Oldest Company Age 2 yrs
Largest company Innopeptichem Life Sciences Private Limited · ₹3.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 May 20242024₹3.3 Lakh (FY 2025)Active

Board colleagues of Jala Ranjith

NameDINCompanyDesignation
Challa Divya10643894Innopeptichem Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Innopeptichem Life Sciences Private Limited
Premium access

Shareholding and investment profile for Jala Ranjith

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jala Ranjith

Jala Ranjith currently holds 1 directorship: Innopeptichem Life Sciences Private Limited (Director, since 31 May 2024, revenue ₹3.3 Lakh (FY 2025)).

Jala Ranjith was first appointed on 31 May 2024 as Director at Innopeptichem Life Sciences Private Limited.

The current boards of Jala Ranjith's companies include Challa Divya (Innopeptichem Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available